Multiparametric Magnetic Resonance Imaging Guided Diagnostic Biopsy Detects Significant Prostate Cancer and could Reduce Unnecessary Biopsies and Over Detection: A Prospective Study

Schroder, 2008, Early detection of prostate cancer in 2007. Part 1: PSA and PSA kinetics, Eur Urol, 53, 468, 10.1016/j.eururo.2007.10.047

Bjurlin, 2013, Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing, J Urol, 189, 2039, 10.1016/j.juro.2013.02.072

Heijnsdijk, 2009, Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer, Br J Cancer, 101, 1833, 10.1038/sj.bjc.6605422

Onik, 2009, Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management, J Clin Oncol, 27, 4321, 10.1200/JCO.2008.20.3497

Villeirs, 2011, Combined magnetic resonance imaging and spectroscopy in the assessment of high grade prostate carcinoma in patients with elevated PSA: a single-institution experience of 356 patients, Eur J Radiol, 77, 340, 10.1016/j.ejrad.2009.08.007

Tanimoto, 2007, Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging, J Magn Reson Imaging, 25, 146, 10.1002/jmri.20793

Sciarra, 2011, Advances in magnetic resonance imaging: how they are changing the management of prostate cancer, Eur Urol, 59, 962, 10.1016/j.eururo.2011.02.034

Thompson, 2013, The role of magnetic resonance imaging in the diagnosis and management of prostate cancer, BJU Int, 112, 6, 10.1111/bju.12381

Rais-Bahrami, 2013, Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer, J Urol, 190, 1721, 10.1016/j.juro.2013.05.052

Barentsz, 2012, ESUR prostate MR guidelines 2012, Eur Radiol, 22, 746, 10.1007/s00330-011-2377-y

Dickinson, 2013, Scoring systems used for the interpretation and reporting of multiparametric MRI for prostate cancer detection, localization, and characterization: could standardization lead to improved utilization of imaging within the diagnostic pathway?, J Magn Reson Imaging, 37, 48, 10.1002/jmri.23689

Epstein, 1994, Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer, JAMA, 271, 368, 10.1001/jama.1994.03510290050036

Wolters, 2011, A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial, J Urol, 185, 121, 10.1016/j.juro.2010.08.082

Bangma, 2013, Active surveillance for low-risk prostate cancer, Crit Rev Oncol Hematol, 85, 295, 10.1016/j.critrevonc.2012.07.005

Landis, 1977, The measurement of observer agreement for categorical data, Biometrics, 33, 159, 10.2307/2529310

Chen, 2008, Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined, Acta Radiol, 49, 602, 10.1080/02841850802004983

Numao, 2013, Usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer, J Urol, 190, 502, 10.1016/j.juro.2013.02.3197

Arumainayagam, 2013, Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard, Radiology, 268, 761, 10.1148/radiol.13120641

Portalez, 2012, Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients, Eur Urol, 62, 986, 10.1016/j.eururo.2012.06.044

Roethke, 2014, Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla, Eur Radiol, 24, 344, 10.1007/s00330-013-3017-5

Kuru, 2013, Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer, J Urol, 190, 1380, 10.1016/j.juro.2013.04.043

Delongchamps, 2013, Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies, J Urol, 189, 493, 10.1016/j.juro.2012.08.195

Kasivisvanathan, 2013, Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer, J Urol, 189, 860, 10.1016/j.juro.2012.10.009

Siddiqui, 2013, Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy, Eur Urol, 64, 713, 10.1016/j.eururo.2013.05.059

Rastinehad, 2014, Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion-guided prostate biopsy, J Urol, 191, 1749, 10.1016/j.juro.2013.12.007

Moore, 2013, Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review, Eur Urol, 63, 125, 10.1016/j.eururo.2012.06.004

Cavadas, 2010, Prostate cancer prevention trial and European randomized study of screening for prostate cancer risk calculators: a performance comparison in a contemporary screened cohort, Eur Urol, 58, 551, 10.1016/j.eururo.2010.06.023

Fine, 2012, A contemporary update on pathology reporting for prostate cancer: biopsy and radical prostatectomy specimens, Eur Urol, 62, 20, 10.1016/j.eururo.2012.02.055

Ross, 2012, Do adenocarcinomas of the prostate with Gleason score (GS) </=6 have the potential to metastasize to lymph nodes?, Am J Surg Pathol, 36, 1346, 10.1097/PAS.0b013e3182556dcd

Bratan, 2013, Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study, Eur Radiol, 23, 2019, 10.1007/s00330-013-2795-0